These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34101994)

  • 1. Evidence for a low-penetrant extended phenotype of rhabdoid tumor predisposition syndrome type 1 from a kindred with gain of SMARCB1 exon 6.
    Kordes U; Mautner VF; Oyen F; Hagel C; Hartmann C; Heuser M; Frühwald M; Hasselblatt M; Oehl-Huber K; Siebert R; Schneppenheim R; Schüller U
    Pediatr Blood Cancer; 2021 Oct; 68(10):e29185. PubMed ID: 34101994
    [No Abstract]   [Full Text] [Related]  

  • 2. Rhabdoid tumor predisposition syndrome with renal tumor 10 years after brain tumor.
    Fukushima H; Yamasaki K; Sakaida M; Tsujio N; Okuno T; Ishii N; Okada K; Fujisaki H; Matsusaka Y; Sakamoto H; Yoneda A; Hara J; Inoue T
    Pathol Int; 2021 Feb; 71(2):155-160. PubMed ID: 33378586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of SMARCB1 constitutional abnormalities including mosaicism in malignant rhabdoid tumors.
    Shirai R; Osumi T; Terashima K; Kiyotani C; Uchiyama M; Tsujimoto S; Yoshida M; Yoshida K; Uchiyama T; Tomizawa D; Shioda Y; Sekiguchi M; Watanabe K; Keino D; Ueno-Yokohata H; Ohki K; Takita J; Ito S; Deguchi T; Kiyokawa N; Ogiwara H; Hishiki T; Ogawa S; Okita H; Matsumoto K; Yoshioka T; Kato M
    Eur J Hum Genet; 2020 Aug; 28(8):1124-1128. PubMed ID: 32218533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelioid Sarcoma Arising in a Long-Term Survivor of an Atypical Teratoid/Rhabdoid Tumor in a Patient With Rhabdoid Tumor Predisposition Syndrome.
    Baker TG; Lyons MJ; Leddy L; Parham DM; Welsh CT
    Pediatr Dev Pathol; 2021; 24(2):164-168. PubMed ID: 33470921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two molecularly distinct atypical teratoid/rhabdoid tumors (or tumor components) occurring in an infant with rhabdoid tumor predisposition syndrome 1.
    Thomas C; Knerlich-Lukoschus F; Reinhard H; Johann PD; Sturm D; Sahm F; Bens S; Vogt J; Nemes K; Oyen F; Kordes U; Siebert R; Schneppenheim R; Messing-Jünger M; Pietsch T; von Deimling A; Paulus W; Pfister SM; Kool M; Frühwald MC; Hasselblatt M
    Acta Neuropathol; 2019 May; 137(5):847-850. PubMed ID: 30945057
    [No Abstract]   [Full Text] [Related]  

  • 6. Rhabdoid tumor predisposition syndrome caused by SMARCB1 constitutional deletion: prenatal detection of new case of recurrence in siblings due to gonadal mosaicism.
    Gigante L; Paganini I; Frontali M; Ciabattoni S; Sangiuolo FC; Papi L
    Fam Cancer; 2016 Jan; 15(1):123-6. PubMed ID: 26342593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition Syndrome.
    Foulkes WD; Kamihara J; Evans DGR; Brugières L; Bourdeaut F; Molenaar JJ; Walsh MF; Brodeur GM; Diller L
    Clin Cancer Res; 2017 Jun; 23(12):e62-e67. PubMed ID: 28620006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor.
    Thomas C; Oehl-Huber K; Bens S; Soschinski P; Koch A; Nemes K; Oyen F; Kordes U; Kool M; Frühwald MC; Hasselblatt M; Siebert R
    Genes Chromosomes Cancer; 2021 Aug; 60(8):586-590. PubMed ID: 33896072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SMARCB1-deficient Tumors of Childhood: A Practical Guide.
    Pawel BR
    Pediatr Dev Pathol; 2018; 21(1):6-28. PubMed ID: 29280680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cribriform neuroepithelial tumor: molecular characterization of a SMARCB1-deficient non-rhabdoid tumor with favorable long-term outcome.
    Johann PD; Hovestadt V; Thomas C; Jeibmann A; Heß K; Bens S; Oyen F; Hawkins C; Pierson CR; Aldape K; Kim SP; Widing E; Sumerauer D; Hauser P; van Landeghem F; Ryzhova M; Korshunov A; Capper D; Jones DTW; Pfister SM; Schneppenheim R; Siebert R; Paulus W; Frühwald MC; Kool M; Hasselblatt M
    Brain Pathol; 2017 Jul; 27(4):411-418. PubMed ID: 27380723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional relevance of genes predicted to be affected by epigenetic alterations in atypical teratoid/rhabdoid tumors.
    Tegeder I; Thiel K; Erkek S; Johann PD; Berlandi J; Thatikonda V; Frühwald MC; Kool M; Jeibmann A; Hasselblatt M
    J Neurooncol; 2019 Jan; 141(1):43-55. PubMed ID: 30446899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphoproteomic analysis reveals Smarcb1 dependent EGFR signaling in Malignant Rhabdoid tumor cells.
    Darr J; Klochendler A; Isaac S; Geiger T; Eden A
    Mol Cancer; 2015 Sep; 14():167. PubMed ID: 26370283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors.
    Biegel JA; Tan L; Zhang F; Wainwright L; Russo P; Rorke LB
    Clin Cancer Res; 2002 Nov; 8(11):3461-7. PubMed ID: 12429635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations of the hSNF5/INI1 gene in renal rhabdoid tumors with second primary brain tumors.
    Savla J; Chen TT; Schneider NR; Timmons CF; Delattre O; Tomlinson GE
    J Natl Cancer Inst; 2000 Apr; 92(8):648-50. PubMed ID: 10772683
    [No Abstract]   [Full Text] [Related]  

  • 15. Gene of the month: SMARCB1.
    Kalimuthu SN; Chetty R
    J Clin Pathol; 2016 Jun; 69(6):484-9. PubMed ID: 26941181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE Host Genome Working Group.
    Frühwald MC; Nemes K; Boztug H; Cornips MCA; Evans DG; Farah R; Glentis S; Jorgensen M; Katsibardi K; Hirsch S; Jahnukainen K; Kventsel I; Kerl K; Kratz CP; Pajtler KW; Kordes U; Ridola V; Stutz E; Bourdeaut F
    Fam Cancer; 2021 Oct; 20(4):305-316. PubMed ID: 33532948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sellar Region Atypical Teratoid/Rhabdoid Tumors (ATRT) in Adults Display DNA Methylation Profiles of the ATRT-MYC Subgroup.
    Johann PD; Bens S; Oyen F; Wagener R; Giannini C; Perry A; Raisanen JM; Reis GF; Nobusawa S; Arita K; Felsberg J; Reifenberger G; Agaimy A; Buslei R; Capper D; Pfister SM; Schneppenheim R; Siebert R; Frühwald MC; Paulus W; Kool M; Hasselblatt M
    Am J Surg Pathol; 2018 Apr; 42(4):506-511. PubMed ID: 29324471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of desmoplastic myxoid tumor, SMARCB1 mutant, in the pineal region.
    Wang YE; Chen JJ; Wang W; Zhang AL; Zhou W; Wu HB
    Neuropathology; 2021 Feb; 41(1):37-41. PubMed ID: 32901946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conventional chondrosarcoma in a survivor of rhabdoid tumor: enlarging the spectrum of tumors associated with SMARCB1 germline mutations.
    Forest F; David A; Arrufat S; Pierron G; Ranchere-Vince D; Stephan JL; Clemenson A; Delattre O; Bourdeaut F
    Am J Surg Pathol; 2012 Dec; 36(12):1892-6. PubMed ID: 23154773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of Smarcb1 and Nf2 inactivation determines schwannoma versus rhabdoid tumor development.
    Vitte J; Gao F; Coppola G; Judkins AR; Giovannini M
    Nat Commun; 2017 Aug; 8(1):300. PubMed ID: 28824165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.